 prospect random evalu intensive-cours doxorubicin surgic adjuv chemotherapi resect gastric cancer studi combin postop adjuv chemotherapi patient cur resect primari gastric adenocarcinoma twenty-f elig evalu patient extent surgic resect locat primari tumor stomach node statu receiv cycl chemotherapi median time patient entri year result signific differ time surviv rate observ arm adjuv therapi arm data improv surviv rate patient chemotherapi valu drug-rel fatal due result substant benefit chemotherapi regimen postop adjuv treatment resect gastric cancer